Tracking Weekly Auvelity Prescriptions

Axsome Therapeutics lead drug Auvelity, recorded a new prescription high of 9,125 this past week. The FDA approved Auvelity for MDD late 2022, and commercial launch followed. Data reported from IQVIA. Weekly prescription chart below. Thank you for reading.